Sessions are scheduled in local time (CEST)
Munich Hall
Industry Satellite Symposium
Date
Thu, 11.05.2023
Time
18:30 - 19:30
Room
Munich Hall
Chairs
- Peter A. Fasching (Erlangen, Germany)
MSD - Perspectives on the treatment of HER2-negative gBRCAm early breast cancer (ID 25)
Introductions (ID 955)
Lecture Time
18:30 - 18:35
Session Name
Room
Munich Hall
Date
Thu, 11.05.2023
Time
18:30 - 19:30
Speakers
- Peter A. Fasching (Erlangen, Germany)
MSD - Perspectives on the treatment of HER2-negative gBRCAm early breast cancer (ID 25)
Evolving treatment landscape in HER2-negative gBRCAm patients (ID 956)
Lecture Time
18:35 - 18:55
Session Name
Room
Munich Hall
Date
Thu, 11.05.2023
Time
18:30 - 19:30
Speakers
- Karen A. Gelmon (Vancouver, British Columbia, Canada)
MSD - Perspectives on the treatment of HER2-negative gBRCAm early breast cancer (ID 25)
Patient case study (ID 957)
Lecture Time
18:55 - 19:10
Session Name
Room
Munich Hall
Date
Thu, 11.05.2023
Time
18:30 - 19:30
Speakers
- Rupert Bartsch (Vienna, Austria)
MSD - Perspectives on the treatment of HER2-negative gBRCAm early breast cancer (ID 25)
Q&A / discussion (ID 958)
Lecture Time
19:10 - 19:25
Session Name
Room
Munich Hall
Date
Thu, 11.05.2023
Time
18:30 - 19:30
MSD - Perspectives on the treatment of HER2-negative gBRCAm early breast cancer (ID 25)
Closing (ID 959)
Lecture Time
19:25 - 19:30
Session Name
Room
Munich Hall
Date
Thu, 11.05.2023
Time
18:30 - 19:30
Speakers
- Peter A. Fasching (Erlangen, Germany)